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Aneuploidy, a chromosomal numerical abnormality in the conceptus or fetus, occurs in at least 5% of all pregnancies and is the leading
cause of early pregnancy loss in humans. Accumulating evidence now suggests that the correct segregation of chromosomes is affected
by events occurring in prophase during meiosis I. These events include homologous chromosome pairing, sister-chromatid cohesion,
and meiotic recombination. In our current study, we show that mutations in SYCP3, a gene encoding an essential component of the
synaptonemal complex that is central to the interaction of homologous chromosomes, are associated with recurrent pregnancy loss.
Two out of 26 women with recurrent pregnancy loss of unknown cause were found to carry independent heterozygous nucleotide alter-
ations in this gene, neither of which was present among a group of 150 fertile women. Analysis of transcripts fromminigenes harboring
each of these two mutations revealed that both affected normal splicing, possibly resulting in the production of C-terminally mutated
proteins. The mutant proteins were found to interact with their wild-type counterpart in vitro and inhibit the normal ﬁber formation of
the SYCP3 protein when coexpressed in a heterologous system. These data suggest that thesemutations are likely to generate an aberrant
synaptonemal complex in a dominant-negativemanner and contribute to abnormal chromosomal behavior thatmight lead to recurrent
miscarriage. Combined with the fact that similar mutations have been previously identiﬁed in two males with azoospermia, our current
data suggest that sexual dimorphism in response to meiotic disruption occurs even in humans.Introduction
Aneuploidy, trisomy or monosomy in the conceptus or
fetus, occurs in at least 5% of all pregnancies and is
a common reproductive problem in humans.1 Some
fetuses with aneuploidy survive to term but suffer from
disorders associated with congenital anomalies and also
mental retardation, such as Down syndrome ([MIM
190685]). However, most aneuploid conceptuses die in
utero, resulting in early pregnancy loss. In addition,
whereas approximately 15% of all clinically recognized
pregnancies are lost between the 6th and 10th week, more
than 50% of these cases are due to numerical cytogenetic
errors.2,3 Signiﬁcantly, although it is the leading cause of
early pregnancy loss, the precise underlying mechanism
of aneuploidy remains poorly understood.
There is an emerging consensus that a woman with
a previous aneuploid conception has an increased risk of
recurrence of the same or a different aneuploidy.4,5 Indeed,
a subset of women are susceptible to repeat miscarriages,
referred to as recurrent pregnancy loss (RPL). RPL is, in
fact, a serious reproductive problem affecting approxi-
mately 5% of couples trying to conceive.3 RPL has been
historically attributed to genetic, structural, infective,
endocrine, immunological, or unexplained causes.2
Although a currently prevailing hypothesis is that RPL
might be a polygenic disorder, associated with both genetic14 The American Journal of Human Genetics 84, 14–20, January 9, 2and environmental determinants, it is also possible that
this condition develops as a single-gene disorder.
Aneuploidy occurs as a consequence of the nondisjunc-
tion of homologous or sister chromosomes during meiosis
I or II. A considerable body of evidence has recently been
accumulated in a number of reports in relation to how
the meiotic machinery is involved in nondisjunction.
There is an emerging consensus that the events that occur
during prophase in meiosis I are essential for the proper
segregation of homologous or sister chromosomes. These
include synapsis between homologous chromosomes and
cohesion between sister chromosomes, as well as the loca-
tion and frequency of meiotic recombination.6-8 It has also
been logically hypothesized that genetic defects in these
meiotic events induce a greater susceptibility to nondis-
junction and the generation of an aneuploid conceptus.9
Given that mice deﬁcient for these genes exclusively mani-
fest reproduction failure without the appearance of any
extragonadal symptoms, it is also not unreasonable to
hypothesize that human infertility and RPL are caused by
mutations in such meiotic genes.
The synaptonemal complex comprises a tripartite
protein structure that promotes the connection of homol-
ogous chromosomes during prophase in meiosis I. SYCP3
([MIM 604759]) is an essential component of the axial
or lateral element of the synaptonemal complex
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Figure 1. Characterization of Two SYCP3 Gene Mutations Identified in Women with RPL
(A) Schematic representation of the synaptonemal complex. Abbreviations are as follows: AE, axial element; LE, lateral element; CE,
central element. SYCP3 is an essential component of the AE or LE.
(B) The c.IVS7–16_19delACTT mutation. The upper panel indicates the sequence found in case 46, whereas the lower panel indicates that
of a control subject. The deleted nucleotides are boxed.
(C) The c.657T/C mutation. The upper panel indicates the sequence found in case 14, whereas the lower panel indicates that of a control
subject. The identified heterozygous mutation is indicated by ‘‘N.’’
(D) Localization of the two SYCP3 mutations identified in this study. Boxes indicate exons and black triangles indicate locations of the
mutations. c.643delA is the mutation that was previously identified in azoospermia patients.13are sterile as a result of the onset of meiotic arrest.12 This is
consistent with the fact that a mutation in SYCP3 was
identiﬁed in two human patients with azoospermia
([MIM 270960]).13 Notably, the phenotype of mice
harboring a SYCP3 deﬁciency differs between males and
females. Whereas male mice are completely infertile due
to meiotic arrest, female mice are subfertile, with a severely
reduced oocyte pool. Although two thirds of offspring are
healthy, one third is affected by aneuploidy and succumbs
during development in utero.14 Hence, SYCP3 is a strong
candidate gene for human RPL. In our current study, we
screened for mutations in the SYCP3 gene among a cohort
of women who suffer from RPL.
Subjects and Methods
Samples
A total of 26 Japanese women with a history of RPL (more than
three consecutive pregnancy losses) of unknown cause were
enrolled in this study.Noneof these individualshas a familyhistory
of birth defects. RPL cases of known cause, such as hormonal, struc-
tural, immunological, and coagulation disorders, were excluded.
All of thewomenwere examined byultrasonographyor hysterosal-
pingography for detectionof anatomic abnormalities of the genitalThe Atract, and all had blood drawn for testing for immunological risk
factors, including natural killer cell activity, anti-nuclear anti-
bodies, and phospholipid antibodies, such as lupus anti-coagulant.
Screening for thrombophilia, with the measurement of plasma
levels of antithrombin and proteins C and S, was performed. Blood
tests for hyperthyroidism, diabetes mellitus, hyperprolactinemia,
and infections, such as chlamydia, were also evaluated. Cytoge-
netic analyses demonstrated anormal karyotype in all of these indi-
viduals, as well as in their partners, but were not performed in all of
the abortuses. Peripheral-blood samples were drawn at the clinic
after appropriate informed consent was obtained. A total of 150
blood samples from Japanese women with at least one child and
no history of infertility or miscarriage were used as controls. The
study was approved by the Ethical Review Board for Human
Genome Studies at Fujita Health University.
DNA Analysis
Genomic DNA was extracted from peripheral-blood samples with
PureGene (Gentra). Oligonucleotide primers were designed to
amplify each coding sequence, as well as the exon-intron bound-
aries of the human SYCP3 gene, which contains 9 exons (GenBank
accession no. NM_153694). PCR was performed under standard
conditions. After the removal of unincorporated primers and
excess dNTPs by exonuclease I and shrimp alkaline phosphatase
(ExoSAP-IT, USB), the ampliﬁed fragments were directly sequenced
with the use of the same primer sets.merican Journal of Human Genetics 84, 14–20, January 9, 2009 15
RNA Analysis
The SYCP3 genomic region encompassing exon 8 and a part of
introns 7 and 8 was ampliﬁed for both wild-type (WT) andmutant
alleles. The resulting PCR products were then subcloned into the
intronic region of a mammalian expression vector (Exontrap,
MoBiTec). These plasmids were then transfected into HEK293 or
HeLa cells with Lipofectamine 2000 (Invitrogen). Cells were har-
vested at 48 hr after transfection, and total RNA extracts were iso-
lated with RNeasy (QIAGEN). After treatment with DNase I, ﬁrst-
strand cDNAswere synthesizedwith the use of an oligo(dT) primer
and Superscript III (Invitrogen). RT-PCR was then performed with
primers designed with vector sequences. PCR products were
resolved in 2% agarose gels and evaluated with ImageJ software.
For expression inmeiotic cells, the vector promoter was replaced
with the mouse Sycp1 promoter (722/þ102).15,16 The resultant
plasmids were then injected into the rete testis, because this
produced less damage to testicular tissue than injections into
seminiferous tubules or direct injection into the parenchyma of
the testis. We used a 4-wk-old DDYmouse without elongated sper-
matids or mature sperm, which might inhibit successful transfec-
tion into spermatocytes. The plasmids were introduced into the
meiotic cells by in vivo electroporation with a CUY21 electropora-
tor (BEX).17 The electroporation settings involved eight pulses of
30 V, with a 50 ms pulse length and a 950 ms interval. Testicular
tissue was resected at 24 hr after transfection, and RT-PCR was per-
formed with similar primers. The protocols adopted for the use of
laboratory mice were approved by the Animal Care and Use
Committee at Fujita Health University.
Immunoprecipitations
We cloned cDNAs encoding the WT and C-terminally truncated
mutant human SYCP3 protein into the pET9 (Novagen) and
pT7-FLAG (Sigma) vectors to obtain N-terminal T7- or FLAG-
tagged proteins, respectively. These recombinant proteins were
subsequently expressed in Rosetta DE3 competent cells (Nova-
gen). FLAG-tagged WT proteins were ﬁrst bound to anti-FLAG
afﬁnity gel (Sigma) for 30 min and then incubated with each
T7-tagged WT or mutant protein for 1 hr. After washing, the
proteins were eluted with 0.1 M citric acid pH2.2, followed by
neutralization with 2M Tris base pH10.4. Western blotting was
performed with FLAG antibodies (M2, Sigma) or T7 antibodies
(Novagen) and evaluated with ImageJ software.
Expression in Mammalian Cell Lines
cDNAs encoding the WT mouse SYCP3 protein and its C-terminal
truncated mutants were cloned into the pFLAG-CMV2 (Sigma)
and pCMV-Tag3 (Stratagene) vectors for expression of N-terminal
FLAG- or myc-tagged protein, respectively. These expression
vectors were then either solely transfected or cotransfected into
COS-7 cells. At 24 hr after transfection, the expressed proteins
were detected with FLAG-M2 or myc antibodies (A-14, Santa
Cruz Biotechnology). Alexa 488-conjugated donkey anti-mouse
IgG and Alexa 594-conjugated donkey anti-rabbit IgG (Molecular
Probes) were used as secondary antibodies for detection by ﬂuores-
cence microscopy.
Results
We identiﬁed heterozygous point mutations within the
SYCP3 gene in two of the women with RPL in our study16 The American Journal of Human Genetics 84, 14–20, January 9, 2cohort. One mutation was found in case 46 (39 years old,
three miscarriages between six and ten weeks of gestation,
no liveborns) and identiﬁed as c.IVS7–16_19delACTT
(Figures 1B and 1D). This mutation is located at the puta-
tive branch site of intron 7 and possibly affects the normal
splicing of the intron, inducing skipping of the next exon
or partial skipping via a cryptic splice site in the exon. The
other SYCP3 mutation was found in case 14 (29 years old,
three miscarriages between six and ten weeks of gestation,
no liveborns) and identiﬁed as c.657T/C in exon 8
(Figure 1C). Although this secondmutation does not affect
the encoded amino acid at this position (Thr), it is located
at the extreme end of the exon and thus might also affect
normal splicing, inducing skipping of the exon or partial
intron inclusion via a cryptic splice site in the intron
(Figure 1D). These changes do not appear in the NCBI data-
base for single-nucleotide polymorphisms (SNPs). Neither
of these nucleotide substitutions was found among the
150 control fertile women that we tested.
To examine how the c.IVS7–16_19delACTT and
c.657T/C mutations might affect splicing events during
SYCP3 transcription, we constructed expression vectors
encoding minigenes with or without these mutations.
When the expression vector harboring c.IVS7–16_19
delACTT was introduced into human cultured somatic
cell lines, RT-PCR analysis revealed that a signiﬁcant
fraction of the SYCP3 transcripts were shorter than WT
and did not include exon 8 (Figure 2A). This skipping of
exon 8 gives rise to an in-frame deletion resulting in a
C-terminal truncation. We did not observe a similar
abnormal-splicing phenomenon for the c.657T/C
mutant in this experiment.
To further examine the effects of the c.657T/C muta-
tion upon SYCP3 splicing, aminigene harboring this muta-
tion was introduced directly into mouse testes by in vivo
electroporation. When we ﬁrst examined the transfection
efﬁciency with a GFP-expression vector, the plasmids
were found to be transfected with a far higher efﬁciency
in somatic cells but less so inmeiotic cells.We then utilized
the Sycp1 promoter to restrict this expression to meiotic
cells. We speculated that because this base substitution
occurred at the last nucleotide of exon 8, an overlarge tran-
script bearing intron 8 might be generated as a result of
a read through of the splicing junction. Although themini-
gene construct for the WT SYCP3 gene produced small
amounts of such transcripts in this experiment, the
c.657T/C mutant-expression vector generated much
more aberrant transcripts (Figure 2B). The ratio of un-
spliced/spliced transcripts was signiﬁcantly higher for the
c.657T/C mutant than for the WT. In contrast, the
abnormal transcript detected for the c.IVS7–16_19
delACTT mutation in the previous assay using somatic
cells was not observed in this assay (data not shown).
Because both of the women with RPL who harbored
SYCP3 mutations were heterozygous for the identiﬁed
substitutions and no other mutations were evident on
the WT allele, we looked for possible effects of interactions009
Figure 2. Effects of the Identified
Mutations upon Normal Splicing
(A) RT-PCR analysis of SYCP3 minigenes
transfected into HEK293 cells. Lane M,
size markers; lane 1, untransfected parental
cells; lane 2, wild-type (WT) SYCP3; lane 3,
c.657T/C mutant; lane 4, c.IVS7–
16_19delACTT mutant; lane 5, vector
without exon 8; lane 6, no template-DNA
control. The sizes of the PCR products are
indicated on the right of the panels. The
origin of each PCR product is indicated in
the middle panels. Boxes indicate exons
within the expression vector, whereas
triangles depict the regions homologous
to the PCR primers. Bold horizontal lines
indicate the transcribed regions. The lower
panel indicates semiquantification of the
PCR products for WT and for the c.IVS7–
16_19delACTT mutant. The given data are
the mean values of three independent
experiments. Vertical bars indicate the
standard deviation. Similar results were
observed when these constructs were trans-
fected into HeLa cells.
(B) RT-PCR analysis of SYCP3 minigenes under the control of the Sycp1 promoter transfected into mouse testicular cells. Lane M, size
markers; lane 1, WT SYCP3; lane 2, c.657T/C mutant. The lower panel shows the semiquantification of the PCR products for WT and
for the c.657T/C mutant. Open boxes indicate the normal transcript, whereas closed boxes indicate an abnormal transcript with an
intron retention. Ratio of intensity corresponding to these two PCR products was significantly different between WT and the
c.657T/C mutant. Vertical bars indicate the standard deviation (Student’s t test, p < 0.000005).between the mutant andWT SYCP3 proteins. On the basis
of the assumptions that the mutated SYCP3 allele in case
46 (c.IVS7–16_19delACTT) produces a C-terminally trun-
cated SYCP3 protein as a result of the exclusion of
exon 8 and that that found in case 14 (c.657T/C)
produces a C-terminal mutant extended protein as a result
of the inclusion of intron 8 (Figure 3A), we constructed
expression vectors that produced these mutant products
and the WT SYCP3 protein. We ﬁrst analyzed the in vitro
interaction between recombinant proteins produced using
Figure 3. Interactions between Wild-
Type and Mutant SYCP3 Proteins
(A) Schematic diagram showing the struc-
ture of the wild-type (WT) and putative
mutant SYCP3 proteins. Dotted and hatched
boxes indicate peptide regions encoded by
exons 8 and 9, respectively. The c.IVS7–
16_19 delACTT mutant is predicted to
produce a C-terminally truncated protein
via the exclusion of exon 8. The c.657T/C
mutant is predicted to produce a C-termi-
nally mutated protein resulting from the
inclusion of intron 8 (black box). The
c.643delA allele is predicted to produce
C-terminally truncated protein via a frame-
shift.
(B) Interactions between various SYCP3
proteins. After immunoprecipitation with
FLAG antibodies, coprecipitated proteins
were detected with T7 antibodies. Lane 1,
WT SYCP3; lane 2, c.643delA mutant; lane 3, c.657T/C mutant; lane 4, c.IVS7–16_19delACTT mutant; lane 5, bacterial alkaline phos-
phatase (BAP) negative control.
(C) Semiquantification of the western blot. The height of the boxes represents the mean of value relative to that of WT obtained from
three independent experiments. Vertical bars indicate the standard deviation. Asterisk indicates p < 0.005 (Student’s t test).The American Journal of Human Genetics 84, 14–20, January 9, 2009 17
Figure 4. Characterization of SYCP3
Fiber Formation
(A) Microscopic observation of SYCP3 fibers
produced in COS-7 cells. N-terminal FLAG-
or myc-tagged wild-type (WT) SYCP3
proteins form a loop-like fiber structure,
whereas the currently identified mutants
appear to form short rod-like structures.
(B) Effects of the coexpression of FLAG-
tagged WT and mutant SYCP3 proteins
(green) upon the fiber formation of myc-
tagged WT SYCP3 protein (red). WT SYCP3
forms typical loop-like structures even in
the presence of differently tagged WT
SYCP3 (upper panel). However, coexpressed
mutant SYCP3 proteins (c.657T/C and
c.IVS7delACTT) colocalize with their WT
counterparts and disrupt the complex fiber
conformations to yield shorter products.
The levels of inhibition appear dependent
on the amount of mutant protein (lower
panels).an E. coli-expression system. WT SYCP3 proteins that were
differentially tagged at the N terminus were found to coim-
munoprecipitate each other (Figures 3B and 3C). The two
mutant SYCP3 proteins also interacted with their WT
counterpart, although this afﬁnity was weaker than that
between the WT proteins. The c.643delA frameshift muta-
tion previously found in azoospermia patients has been
predicted to also produce a C-terminally mutated SYCP3
protein,13 and this was found to be the case with the
mutants identiﬁed in this study.
The ﬁber-forming properties of the self-assembling
SYCP3 protein can be analyzed in cultured somatic cells.
Therefore, to analyze the effects of the c.IVS7–16_19
delACTT and c.657T/C mutations upon this ﬁber-forma-
tion process, we expressed the corresponding mutant and
WT SYCP3 proteins in COS-7 cells. TheWT SYCP3 protein,18 The American Journal of Human Genetics 84, 14–20, January 9, 2as expected, generated a thick ﬁber in a loop-like structure
in the nucleus regardless of the presence of any epitope
tags (Figure 4A). In contrast, the intron-inclusion mutant
(c.657T/C) did not form any ﬁber structure and the
exon-exclusion mutant (c.IVS7–16_19delACTT) formed
only short rod-like ﬁbers. Notably, when these two
mutants were coexpressed with the WT in these cells, we
could not detect the typical loop-like ﬁbers characteristic
of WT SYCP3 and we observed only several short ﬁbers
composed of both WT and mutant proteins (Figure 4B
and Figure 5). This suggests that normal SYCP3-ﬁber
formation is inhibited by the presence of C-terminally
mutated protein. These ﬁndings also suggest that the two
identiﬁed heterozygous mutations are likely to form aber-
rant lateral elements in the synaptonemal complex in
a dominant-negative manner, which would probably
Figure 5. Dose-Dependent Inhibition of SYCP3 Fiber
Formation by Mutant Proteins
Plasmids encoding FLAG-tagged wild-type (WT) SYCP3 were
mixed with various amounts of plasmids encoding myc-tagged
WT or mutant SYCP3, then the mixtures were transfected into
COS-7 cells. We observed a total of 100 cells for each experi-
ment and determined the conformation of the SYCP3 fibers
for each cell. White bars indicate the percentages of cells
with loop-like SYCP3 fibers, whereas black bars indicate
the percentages of cells with short rod-like fibers or other
structures.009
lead to abnormal chromosomal behavior in meiosis I
during oogenesis.
Discussion
In our current study, we have identiﬁed a subset of women
who have a history of RPL and harbor subtle nucleotide
alterations in their SYCP3 genes. Although cytogenetic
studies were not performed on the corresponding aborted
fetuses, these identiﬁedmutations are likely to be causative
for RPL in humans, because this observation is analogous
to the phenotype observed previously in female mice
with a SYCP3 deﬁciency.14 The loss of SYCP3 in female
mice has two effects: a reduced oocyte pool and embryonic
death due to aneuploidy. Our patients did not show the
severe oocyte loss, however, possibly because the identiﬁed
mutations do not completely abrogate SYCP3 function.
Additionally, our patients had no liveborns, although
two-thirds of the offspring are healthy in SYCP3-deﬁcient
female mice. This might be due to differences in check-
point robustness between twomammalian species. Indeed,
mice have rates of aneuploidy that are an order of magni-
tude lower than those observed in humans.9
Both of the screened mutations showed effects upon
normal splicing, resulting in a C-terminally mutated
SYCP3 protein under our experimental conditions.
Although a minigene harboring the c.657T/C mutation
did not show the abnormal transcript in our assay system
using somatic cells, we could detect when the minigene
was expressed in mouse testis under the control of
a meiotic promoter. Recently, the regulation of meiosis-
speciﬁc splicing by a meiotic promoter has been re-
ported.18 On the basis of a previous report showing that
a 50 splice-site mutation often results in exon skipping or
usage of a cryptic splice site, the inclusion of an entire
intron as a result of the c.657T/C mutation is
unusual.19,20 We reasoned that in this instance, no cryptic
site was available, because this intron is short (150 bp). On
the other hand, we did not detect abnormal transcripts
from the minigene harboring c.IVS7–16_19delACTT in
our assay system using mouse testis, possibly because the
region mutated in c.IVS7–16_19delACTT is not conserved
between mice and humans.
Both of the mutations identiﬁed in this study, in addi-
tion to the c.643delA mutation previously found in azoo-
spermia patients, are located within the C-terminal region
of the SYCP3 protein.13 The SYCP3 C terminus is highly
conserved between mice and humans, in terms of not
only the protein structure but also genomic organization.
Hence, this region, encoding one of two coiled-coil motifs
within the conserved Cor1 domain, appears to fulﬁll an
important function in the development of the synaptone-
mal complex.21 Functional domains of the SYCP3 protein
have been examined in detail with the use of multiple-
deletion mutants, and the results of these examinations
appear to be consistent to our results.22The AThe two RPL females that were found to harbor the
SYCP3 mutation were found to be heterozygous for their
respective mutations. Our data also demonstrated that
the resulting C-terminally mutated proteins in both cases
showed weak but substantial interactions with their WT
counterparts. Moreover, their coexpression in cultured
mammalian cells shows that the mutants colocalize with
WT protein, suggesting that they act in concert to form
abnormal SYCP3 ﬁbers. The resultant ﬁbers are short,
possibly as a result of the lower binding afﬁnity of the
mutants, which might interfere with ﬁber elongation or
render the ﬁbers more fragile. The crucial question then
arose as to how these mutant SYCP3 proteins could
contribute to nondisjunction during female meiosis I.
Given that the SYCP3 protein has already disappeared by
the dictyate stage in female mice, it is reasonable to assume
that homologous pairing is partly inhibited prior to the
dictyate stage.23 Quantiﬁcation of RT-PCR products
suggests that the two patients might produce only a small
amount of mutant proteins relative to WT SYCP3. Thus, it
is possible that the SYCP3 ﬁbers can still form a synaptone-
mal complex that is functional enough to repair SPO11-
induced double-strand breaks and escape oocyte loss.
However, it has been speculated that another function of
the synaptonemal complex, assurance and interference
in crossover, might be partly impaired, leading to nondis-
junction in meiosis I.24 We are now investigating the
effects of these mutations upon nondisjunction by intro-
ducing an oligonucleotide corresponding to the SYCP3
splicing junction into mouse oocytes using a primary
culture system.25
Given that mutations in the SYCP3 gene were ﬁrst re-
ported in two out of 19 patients with male infertility,13 it
is intriguing that similar mutations do not cause infertility
but result in RPL in females. However, mice that are deﬁ-
cient in meiotic genes often show different phenotypes
between males and females, and it has been speculated
that the checkpoint systems that mediate the completion
of synapsis in meiotic prophase differ between males and
females.26 Indeed, SYCP3-deﬁcient mice show complete
meiotic arrest leading to infertility in male, whereas in
females this leads to aneuploidy in the oocytes, which
resembles human recurrent pregnancy loss.12,14 Similar
phenotypic discordance was also been reported in mice
with a SMC1B deﬁciency or in those with hypomorphic
mutations in the Rad51c gene.27-29 Our results herein indi-
cate that a similar sexual-dimorphism phenomenon also
exists in humans.
In conclusion, our present data suggest that mutations
in the SYCP3 gene are a predisposing factor for human
nondisjunction. Given that we identiﬁed the SYCP3
mutations only in a subset of RPL women, it is possible
that the remaining women in this study group might
harbor mutations in other meiotic genes. Larger-scale
investigations in the future will be needed for a more
precise elucidation of the etiology of human reproduction
failure.merican Journal of Human Genetics 84, 14–20, January 9, 2009 19
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